PUBMED

 

  
           
 

 Suppression of Angiogenesis

  1. Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia, Italy.

    2. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds.
    Glycobiology. 2007 May;17(5):541-52. Epub 2007 Feb 12. PMID: 17296677 [PubMed - indexed for MEDLINE]

  2. Boisson-Vidal C, Zemani F, Caligiuri G, Galy-Fauroux I, Colliec-Jouault S, Helley D, Fischer AM.

    3. Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algae.
    Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):67-77. Review. PMID: 17266549 [PubMed - indexed for MEDLINE]

  3. Lake AC, Vassy R, Di Benedetto M, Lavigne D, Le Visage C, Perret GY, Letourneur D.

    4. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
    J Biol Chem. 2006 Dec 8;281(49):37844-52. Epub 2006 Oct 6. PMID: 17028197 [PubMed - indexed for MEDLINE]

  4. Matsubara K, Xue C, Zhao X, Mori M, Sugawara T, Hirata T.

    5. Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells.
    Int J Mol Med. 2005 Apr;15(4):695-9. PMID: 15754034 [PubMed - indexed for MEDLINE]

  5. Eichhorn ME, Strieth S, Krasnici S, Sauer B, Teifel M, Michaelis U, Naujoks K, Dellian M.

    6. Protamine enhances uptake of cationic liposomes in angiogenic microvessels.
    Angiogenesis. 2004;7(2):133-41. PMID: 15516834 [PubMed - indexed for MEDLINE]

  6. Luyt CE, Meddahi-Pelle A, Ho-Tin-Noe B, Colliec-Jouault S, Guezennec J, Louedec L, Prats H, Jacob MP, Osborne-Pellegrin M, Letourneur D, Michel JB.

    7. Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia.
    J Pharmacol Exp Ther. 2003 Apr;305(1):24-30. PMID: 12649349 [PubMed - indexed for MEDLINE]

  7. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H.

    8. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
    Biochem Pharmacol. 2003 Jan 15;65(2):173-9. PMID: 12504793 [PubMed - indexed for MEDLINE]

  8. Matou S, Helley D, Chabut D, Bros A, Fischer AM.

    9. Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro.
    Thromb Res. 2002 May 15;106(4-5):213-21. PMID: 12297128 [PubMed - indexed for MEDLINE]

  9. Soeda S, Kozako T, Iwata K, Shimeno H.

    10. Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action.
    Biochim Biophys Acta. 2000 Jun 2;1497(1):127-34. PMID: 10838166 [PubMed - indexed for MEDLINE]

  10. Zugmaier G, Favoni R, Jaeger R, Rosen N, Knabbe C.

    11. Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors.
    Ann N Y Acad Sci. 1999;886:243-8. PMID: 10667230 [PubMed - indexed for MEDLINE]

  11. Taraboletti G, Roberts D, Liotta LA, Giavazzi R.

    12. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.
    J Cell Biol. 1990 Aug;111(2):765-72. PMID: 1696271 [PubMed - indexed for MEDLINE]

 

    
 
   
 
 
 
 
   
  Copyright © 2011 FUCOIDAN WELLNESS CENTER All rights reserved